A B S T R A C T The relationship between Ia-like antigens (Ia-antigens) on human monocytes and the ability of lactoferrin (LF) to inhibit the production of colony stimulatory activity (CSA) for granulocyte and macrophage colony formation was investigated. Complement-dependent cytotoxicity of human monocytes by antiserum to Ia-antigen-reduced CSA production by 50%. LF decreased CSA production by monocytes but had no influence on monocytes insensitive to anti-Ia and complement. Anti-Ia in the absence ofcomplement had no effect on production of CSA but blocked the inhibitory action of LF. This suggests that LF inhibits production of CSA from an Ia-antigen-positive subpopulation of human blood monocytes. This may be of relevance to the regulation of myelopoiesis.
INTRODUCTION
Regulation of myelopoiesis entails interactions between progenitor cells committed to granulocytemacrophage differentiation and stimulatory and inhibitory substances derived from the mature end cells of these lineages (1) . A main cellular source of colony stimulatory activity (CSA)1 for granulocytes and macrophages in humans appears to be the monocyte-macrophage series (1) . Human CSA, candidate in vivo regulators, are macromolecules that induce progenitor cells from bone marrow to form colonies of granulocytes and/or macrophages in semisolid culture (1) . The in vitro and in vivo production of CSA and myelopoiesis in vivo can be suppressed by lactoferrin (LF), an ironbinding glycoprotein found in the secondary granules Dr. Broxmeyer is a Scholar of the Leukemia Society of America.
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A proportion of human monocytes (4-6) and macrophages (7) contain Ia-like (Ia) antigenic determinants. The 28,000-37,000 dalton complex isolated from human B-cell line membranes and produced by genes mapping in the major histocompatibility complex (8) is biochemically similar to the murine I region antigenic (Ia) system.
In the present study, the ability of Ia-antigen-positive subpopulations of human monocytes to produce CSA and the possible relationship of Ia-antigens to receptors for LF were investigated.
METHODS
Bone marrow and blood were obtained from normal volunteers who had given informed consent. Nucleated bone marrow and blood cells were separated by a density "cut" procedure with bovine serum albumin (1.070 g/cm3, 270 mosmol) (1). Low density (<1.070 g/cm3) bone marrow cells were further separated by adherence to plastic (1) to obtain nonadherent low density cells depleted of cells that produce CSA and contained >98% of the granulocyte-macrophage colony-forming cells. Low density blood cells, composed of -50% lymphocytes and 50% monocytes as determined by Wright's and nonspecific esterase staining (9) , were used as the cellular source of CSA or were further separated by adherence to plastic to obtain adherent mononuclear cells (>90% monocytes) (1). Cell viability was assessed using trypan blue stain.
Complement-dependent cytotoxicity and complement-independent studies. Ia-antigen-specific heteroantiserum absorbed against T cells and the B cell-absorbed control sample were generously supplied by Dr. Robert Winchester of The Rockefeller University, New York (4). Dilutions of antiserum or control serum were prepared in McCoy's medium supplemented with 10% heat-inactivated fetal calf serum (FCS). Mononuclear blood cells (5 x 106) in 1.0 ml were incubated with 1.0 ml of antiserum at 4°C for 30 min, washed through FCS, and used or incubated at 37°C for 45 min with 1.0 ml of rabbit complement preselected for absence of heterospecific antibodies (1:10 dilution) and washed through FCS twice (4) .
In some experiments the adherent mononuclear cells were exposed to the antiserum. (2), dialyzed against phosphate-buffered saline for 24 h, and passed through an Amberlite ion exchange IRA 401 column (Mallinckrodt Inc., St. Louis, Mo.) to remove free metal.
Colony assay. Nonadherent low density bone marrow cells (0.8-1.0 x 105) were plated in 0.3% agar in supplemented McCoy's medium with 10% heat-inactivated FCS over feeder layers of mononuclear blood cells suspended in 0.5% agar-culture medium, over 0.5% agar-culture medium layered over adherent mononuclear cells or over culture medium conditioned by adherent mononuclear cells (1) . Colonies (>50 cells) and clusters (3-50 cells) were scored after 7-10 d of incubation. The data are expressed as mean±SE based on counting of five replicate plates. The probability of differences between samples was determined by the use of the Student's t test.
RESULTS
Fig. LA shows one of five similar experiments demonstrating complement-dependent inhibition of the production of CSA from human mononuclear blood cells by a 1:40 dilution of the antiserum to Ia. Treatment of the cells with anti-Ia plus complement inhibited CSA production 48-53%; this was similar to the suppression of CSA production noted with 0.1 uM LF. Cells surviving treatment with antiserum to Ia plus complement were not responsive to suppression by LF. Control serum plus complement or complement alone had no influence on production of CSA or on the inhibition of CSA production by LF. Titration of com- plement-dependent inhibition of CSA production by anti-Ia, shown as the average of two experiments in Fig. 2A , demonstrated inhibition of CSA production which plateaued at 52% using 1:40 to 1:640 dilutions of anti-Ia. Dilutions of anti-Ia >1:2,500 suppressed CSA production with decreasing efficiency. LF did not further suppress CSA production by the cells treated with 1:40 to 1:2,500 dilutions of anti-Ia, but LF maintained maximum inhibition of CSA production after treatment of the cells with higher dilutions of anti-Ia. Treatment of mononucleat blood cells with anti-Ia (1:40 dilution) without complement negated the LFmediated inhibitiorn of CSA production (Fig. IB , one of six similar experimeats). Anti-Ia without complement did not reduce production of CSA but did block the influence of 0.1 ,tM LF in this experiment and 1 ,uM to 0.1 mM LF in two other experiments. Titration of the complement-independent blocking of LF action by anti-Ia is shown as the average of two experiments in Fig. 2B . Suppression of CSA production by LF is completely blocked by 1:40 to 1:160 dilutions and partially blocked by 1:640 to 1:2,500 dilutions of anti-Ia.
40-46% of blood monocytes from three normal donors were killed by a 1:100 dilution of anti-Ia plus complement, and the above results were confirmed for adherent mononuclear blood cells (>90% monocytes) as shown in Fig. 3 . LF (0.1 ,uM) suppressed CSA production by cells pretreated with control medium or complement before adherence of the cells to plastic. Antiserum to Ia (1:100 dilution) plus complement suppressed CSA production; this inhibition was similar to that caused by LF. However, LF did not suppress CSA production from the cells surviving treatment with anti-Ia plus complement (Fig. 3A) . Similar results were obtained when medium conditioned by 0.4 x 105treated blood monocytes from two normal donors was assessed for production of CSA. Antiserum to Ia (1:100 dilution) plus complement reduced CSA production by 45-55%. LF (0.1 ,uM) reduced CSA production from complement-treated cells by 48-59%, but had no influence on the cells treated with anti-Ia plus complement. Antiserum to Ia does not cause the release of monocyte-derived inhibitors against CSA or the colony-forming cells. Medium conditioned by monocytes treated with anti-Ia plus complement (C'), or complement alone, did not reduce colony formation stimulated maximally (81±3 control, 83±5 anti-Ia+C', dilution) after they had adhered to plastic did not influence CSA production or inhibition of CSA production mediated by 0.1 ,uM LF. Anti-Ia (1:100 dilution) did not effect CSA production, but did block the suppressive influence of LF (Fig. 3B ). CSA production was confined to the monocyte fraction as nonadherent mononuclear blood cells (>98% lymphocytes) produced little or no CSA (<10 clusters) when plated at 0.25-2.0 x 106 cells/ml.
DISCUSSION
Human monocytes (4-6) and macrophages (7) are heterogeneous with respect to the presence of Ia-anti-Lactoferrin Inhibition of Production of Colony Stimulatory Activity gens on their surface. It is clear from the present studies that Ia-antigen-positive and Ia-antigen-negative human monocytes produce CSA but it is the Ia-antigenpositive subpopulation of monocytes that is inhibited from producing and/or releasing CSA by LF. Ia-antigens are present on other hematopoietic cells (4) but the blocking of LF action on monocytes by anti-Ia suggests an intimate association between Iaantigens and LF. It has been suggested that human monocytes and mouse macrophages contain specific receptors for LF (10) . Thus, Ia-antigens can act as receptors for LF, Ia-antigens and receptors for LF are structurally different but are in close spatial proximity, or a ligand-induced alteration of Ia-antigens may lead to an interaction with the receptors for LF. LF has been shown to act in vivo in mice (2) and the presence of Ia-antigen-positive monocytes may be of significance to the regulation of myelopoiesis in man. This interaction could depend on heterogeneity of Ia-antigen expression on monocytes, shedding and replacement of Ia-antigens, and the presence of substances that might be able to modulate the numbers or position of Iaantigens on the cell surface. Furthermore, disturbances in the interaction of LF and Ia-antigen-positive monocytes may be involved in the myelopoietic hyperplasia noted in certain leukemias (1) .
